CME Group (CME)Director sold ~$89K
Martin J Gepsman, Director at CME Group, sold ~$89K of CME Group shares.
- ~$89K
- Approx. value · 400 sh @ $222.92
- 25K
- Holds after · shares reported
- Traded
- Nov 4, 2024
- Filed
- Nov 5, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 4, 2024CongressDisclosed sale of CME — reported range $1,001 - $15,000
- Oct 28, 2024InsiderOfficer sold ~$312K of CME shares in the open market
- Oct 30, 2024Insider · 2 peopleInsiders: 3 sales (~$1.2M)
- Nov 4, 2024 · this disclosureInsiderDirector sold ~$89K of CME shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for CME Group
For CME Group, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 60 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CME page.
Other recent filings by Martin J Gepsman, Director
The full history of Martin J Gepsman, Director is on the profile page.
How this filing works
Other disclosures at CME Group
- SEC Form 144Sep 16, 2026
- SEC Form 4Sep 15, 2026
- SEC Form 144Sep 14, 2026
- SEC Form 4Sep 11, 2026
- SEC Form 4Sep 11, 2026
- SEC Form 144Sep 10, 2026
Everything OQRO holds on this company is on its CME page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
